MEDICLIN Aktiengesellschaft Market Cap ($170.05 Million)
Market Cap & Net Worth: MEDICLIN Aktiengesellschaft (MED)
MEDICLIN Aktiengesellschaft market cap. MEDICLIN Aktiengesellschaft (XETRA:MED) has a market capitalization of $170.05 Million (€145.45 Million) as of October 31, 2026. Listed on the XETRA stock exchange, this Germany-based company holds position #16993 globally and #1607 in its home market, demonstrating a -0.93% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying MEDICLIN Aktiengesellschaft's stock price €5.30 by its total outstanding shares 47500000 (47.50 Million).
MEDICLIN Aktiengesellschaft Market Cap History (2015–2026)
MEDICLIN Aktiengesellschaft market cap history from 2015 to 2026. Data shows growth from $226.64 Million to $294.32 Million (3.77% CAGR). Check MED live share price for real-time trading data and today's change.
MEDICLIN Aktiengesellschaft Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how MEDICLIN Aktiengesellschaft's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see MED cash flow conversion for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
0.26x
MEDICLIN Aktiengesellschaft's market cap is 0.26 times its annual revenue
Latest Price to Earnings (P/E) Ratio
8.06x
MEDICLIN Aktiengesellschaft's market cap is 8.06 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $320.34 Million | $580.34 Million | $16.55 Million | 0.55x | 19.36x |
| 2017 | $341.08 Million | $609.10 Million | $3.91 Million | 0.56x | 87.28x |
| 2018 | $316.38 Million | $645.10 Million | $7.72 Million | 0.49x | 41.00x |
| 2019 | $285.99 Million | $673.10 Million | $9.66 Million | 0.42x | 29.60x |
| 2020 | $215.47 Million | $659.90 Million | -$9.00 Million | 0.33x | N/A |
| 2021 | $217.69 Million | $673.10 Million | $1.46 Million | 0.32x | 149.00x |
| 2022 | $199.92 Million | $704.70 Million | $9.44 Million | 0.28x | 21.18x |
| 2023 | $152.16 Million | $730.10 Million | -$10.78 Million | 0.21x | N/A |
| 2024 | $134.39 Million | $748.80 Million | $24.84 Million | 0.18x | 5.41x |
| 2025 | $205.47 Million | $784.49 Million | $25.49 Million | 0.26x | 8.06x |
Competitor Companies of MED by Market Capitalization
Companies near MEDICLIN Aktiengesellschaft in the global market cap rankings as of October 31, 2026. See MED equity to assets ratio to understand what proportion of total assets are financed by equity.
Key companies related to MEDICLIN Aktiengesellschaft by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #284 globally with a market cap of $91.34 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #901 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #987 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1210 globally with a market cap of $20.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #284 | HCA Healthcare, Inc. | NYSE:HCA | $91.34 Billion | $473.19 |
| #901 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €47.80 |
| #987 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1210 | Tenet Healthcare Corporation | NYSE:THC | $20.93 Billion | $273.25 |
Market Capitalization of MEDICLIN Aktiengesellschaft (2015–2026)
Market capitalization of MEDICLIN Aktiengesellschaft from 2015 to today. Between 2015 and today, MEDICLIN Aktiengesellschaft's market cap moved from $226.64 Million to $ 294.32 Million, with a yearly change of 3.77%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €294.32 Million | +43.24% |
| 2025 | €205.47 Million | +52.89% |
| 2024 | €134.39 Million | -11.68% |
| 2023 | €152.16 Million | -23.89% |
| 2022 | €199.92 Million | -8.16% |
| 2021 | €217.69 Million | +1.03% |
| 2020 | €215.47 Million | -24.66% |
| 2019 | €285.99 Million | -9.60% |
| 2018 | €316.38 Million | -7.24% |
| 2017 | €341.08 Million | +6.47% |
| 2016 | €320.34 Million | +41.34% |
| 2015 | €226.64 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of MEDICLIN Aktiengesellschaft was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $170.05 Million USD |
| MoneyControl | $170.05 Million USD |
| MarketWatch | $170.05 Million USD |
| marketcap.company | $170.05 Million USD |
| Reuters | $170.05 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About MEDICLIN Aktiengesellschaft
MEDICLIN Aktiengesellschaft operates hospitals in Germany. The company operates through Post-Acute; Acute; and Nursing Care and Service segments. It offers medical services in the areas of neurology; psychosomatics; orthopedics; internal medicine; cardiology; oncology; geriatrics; psychiatry; otorhinolaryngology; cardiac medicine; rheumatology; gynecology; trauma, heart, and general surgeries; ur… Read more